An April 2021 study University of Guelph looked at an avocado compound that may indicate better ways to treat leukaemia said,
"This is the first time VLCAD [an enzyme] has been identified as a target in any cancer."
Looking for a compound that would inhibit the enzyme they found, "the best one was derived from avocado,"